Sign inJoin waitlistJoin the waitlist

Craig Erickson

Associate Professor · Cincinnati Children's Hospital Medical Center

Credentials: · · · · ·

History

Cincinnati Children's Hospital Medical Center
Present
University of Cincinnati Medical Center Inc.
Present

Child and Adolescent Psychiatry
Indiana University School of Medicine
2006–2008
Psychiatry
Indiana University School of Medicine
2004–2008
University of Cincinnati College of Medicine
1999–2003

Research

Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible
Nature Neuroscience · 2018 · 146 citations
A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome
Journal of Neurodevelopmental Disorders · 2017 · 142 citations
Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome
Molecular Autism · 2017 · 140 citations

Ernest Pedapati
80 papers · 35 as a resident
LW
Logan Wink
52 papers · 10 as a fellow
Rebecca Shaffer
49 papers
Christopher McDougle
43 papers
Kelli Dominick
43 papers · 32 as a resident
KS
Kimberly Stigler
23 papers
DP
David Posey
22 papers
Elizabeth Berry-Kravis
22 papers
Martine Lamy
13 papers · 1 as a resident
David Hessl
12 papers
Steve Wu
12 papers
Donald Gilbert
11 papers

Grants

Mechanistic and Translational Medicine Studies of Brain Neurophysiology and Phenotypic Heterogeneity in Fragile X Syndrome
National Institute of Child Health and Human Development · P50
Contact PI · $3.8M · Cincinnati Childrens Hosp Med Ctr
2025–2030
Leveraging Long-Read Sequencing to Predict Disease Severity in Fragile X Syndrome
National Institute of Child Health and Human Development · R21
Contact PI · $445.5K · Cincinnati Childrens Hosp Med Ctr
2026–2028
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures
NCBDDD · U01
PI · $4.5M · Rush University Medical Center
2021–2027
Translational Medicine and Mechanistic Studies of Brain Neurophysiology in Fragile X Syndrome
National Institute of Child Health and Human Development · U54
Contact PI · $8.1M · Cincinnati Childrens Hosp Med Ctr
2020–2025

Clinical trials

Study of SPG601 in Adult Men With Fragile X Syndrome
Principal investigator · Completed · Phase 2
Spinogenix
2024
Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
Principal investigator · Active not recruiting · Phase 2
Children's Hospital Medical Center, Cincinnati
2022–2026
INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD
Principal investigator · Terminated · Phase 2
Impel Pharmaceuticals
2022–2023
28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder
Principal investigator · Completed · Phase 1
Scioto Biosciences, Inc.
2021–2022